CanBas Co (TSE:4575) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4575 CanBas Co Ltd TSE:4575
34 GF Score
Price 円757.00
View Full Analysis

What is CanBas Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CanBas Co  (TSE:4575) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CanBas Co Cyclically Adjusted PB Ratio Related Terms


CanBas Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for CanBas Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanBas Co Cyclically Adjusted PB Ratio Chart

CanBas Co Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.66 11.08 4.63 10.65 5.87

CanBas Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.28 9.55 7.20 6.56 5.58

TSE:4575 vs VRTX, REGN, MRNA: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, CanBas Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanBas Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CanBas Co's Cyclically Adjusted PB Ratio falls into.


TSE:4575
34GF Score
CanBas Co Ltd TSE:4575
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CanBas Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CanBas Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, CanBas Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=83.34/113.6000*113.6000
=83.340

Current CPI (Jun. 2026) = 113.6000.

CanBas Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 159.512 98.000 184.904
201612 146.854 98.400 169.539
201703 134.188 98.100 155.390
201706 168.740 98.500 194.608
201709 146.149 98.800 168.042
201712 123.861 99.400 141.555
201803 100.762 99.200 115.389
201806 76.640 99.200 87.765
201809 67.374 99.900 76.613
201812 64.210 99.700 73.162
201903 64.233 99.700 73.188
201906 96.038 99.800 109.318
201909 74.998 100.100 85.113
201912 57.245 100.500 64.707
202003 37.904 100.300 42.930
202006 33.670 99.900 38.287
202009 5.787 99.900 6.581
202012 8.688 99.300 9.939
202103 42.990 99.900 48.886
202106 50.122 99.500 57.225
202109 34.304 100.100 38.930
202112 24.509 100.100 27.814
202203 22.638 101.100 25.437
202206 21.729 101.800 24.248
202209 90.493 103.100 99.709
202212 117.033 104.100 127.713
202303 109.060 104.400 118.671
202306 117.850 105.200 127.260
202309 169.507 106.200 181.318
202312 174.813 106.800 185.943
202403 166.102 107.200 176.019
202406 129.882 108.200 136.364
202409 167.596 108.900 174.829
202412 158.151 110.700 162.294
202503 139.742 111.100 142.887
202506 149.413 111.700 151.954
202509 131.713 112.000 133.595
202512 120.623 113.000 121.263
202603 105.278 112.700 106.119
202606 83.340 113.600 83.340

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CanBas Co Business Description

Address 2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
34GF Score

Get the complete analysis for TSE:4575

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円757.00
Price